Want to see TSE:EXE full AI Analyst Report?
EXE Stock Chart & Stats
C$37.91
C$0.02(0.05%)
At close: 4:00 PM EDT
C$37.91
C$0.02(0.05%)
Day’s Range― - ―
52-Week RangeC$12.64 - C$39.14
Previous CloseN/A
Volume282.98K
Average Volume (3M)175.59K
Market Cap
C$3.01B
Enterprise ValueC$3.94K
Total Cash (Recent Filing)C$93.47M
Total Debt (Recent Filing)C$645.75M
Price to Earnings (P/E)23.2
Beta0.41
Next Earnings
Nov 05, 2026EPS Estimate
0.36Next Dividend Ex-DateN/A
Dividend Yield1.6%
Share Statistics
EPS (TTM)1.32
Shares Outstanding95,046,400
10 Day Avg. Volume108,359
30 Day Avg. Volume175,588
Financial Highlights & Ratios
PEG Ratio1.15
Price to Book (P/B)4.88
Price to Sales (P/S)1.10
P/FCF Ratio28.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$38.75Price Target Upside2.22% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)1.53
Revenue Forecast (FY)C$2.29B
Bulls Say, Bears Say
Bulls Say
Materially Improved Balance Sheet And Lower LeverageLeverage falling materially to ~0.9x and a stronger equity base enhances financial flexibility over the medium term. This reduces refinancing and covenant risk, supports capital allocation for redevelopments and M&A, and improves resilience to interest-rate or reimbursement shocks.
Robust Revenue And Home-health Volume GrowthRapid, sustained top-line expansion driven by organic home-health growth and the CBI acquisition signals scalable service demand and successful M&A execution. Diversified revenue streams (LTC, home health, acquisitions) and demographic tailwinds support multi-year structural growth prospects.
Stronger Liquidity And Unsecured Funding ProfileSecuring longer-dated unsecured debt and revolver capacity with lower average rates meaningfully reduces near-term refinancing risk and WACC. A ~C$208M liquidity cushion supports redevelopment pipeline and integration spend, enabling strategic execution without immediate cash strain.
Bears Say
Weak And Volatile Free Cash Flow ConversionSubpar cash conversion and historical FCF volatility constrain internal funding for capex, redevelopments, dividends and deleveraging. Persistent working-capital timing effects and recurring declines reduce the cushion provided by reported earnings and can force external financing under stress.
Home-health Margin Pressure And Funding UncertaintyMargin compression from necessary operational investments and the absence of provincial rate increases points to structural funding and cost risks. Given reliance on provincial funding and wage-driven labor costs, home-health margins may remain constrained until funding catches up or productivity gains absorb investment costs.
Ongoing Integration And Transitional CostsMulti-year integration with recurring transitional costs creates execution risk and delays full synergies. Persistent integration spend can weigh on margins and cash flow, while complexity of region-by-region cutovers increases the chance of operational disruption or slower-than-expected cost savings realization.
Extendicare News
EXE FAQ
What was Extendicare’s price range in the past 12 months?
Extendicare lowest stock price was C$12.64 and its highest was C$39.14 in the past 12 months.
What is Extendicare’s market cap?
Extendicare’s market cap is C$3.01B.
When is Extendicare’s upcoming earnings report date?
Extendicare’s upcoming earnings report date is Nov 05, 2026 which is in 83 days.
How were Extendicare’s earnings last quarter?
Extendicare released its earnings results on Aug 06, 2026. The company reported C$0.319 earnings per share for the quarter, missing the consensus estimate of C$0.395 by -C$0.076.
Is Extendicare overvalued?
According to Wall Street analysts Extendicare’s price is currently Undervalued.
Does Extendicare pay dividends?
Extendicare pays a Monthly dividend of C$0.044 which represents an annual dividend yield of 1.6%. See more information on Extendicare dividends here
What is Extendicare’s EPS estimate?
Extendicare’s EPS estimate is 0.36.
How many shares outstanding does Extendicare have?
Extendicare has 95,046,400 shares outstanding.
What happened to Extendicare’s price movement after its last earnings report?
Extendicare reported an EPS of C$0.319 in its last earnings report, missing expectations of C$0.395. Following the earnings report the stock price went down -5.118%.
Which hedge fund is a major shareholder of Extendicare?
Currently, no hedge funds are holding shares in TSE:EXE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Extendicare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$38.75 (2.22% Upside)
C$38.75 (2.22% Upside)
Insider Transactions
Sold Shares
Worth C$65.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.3%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.69%
12-Months-Change
Fundamentals
Return on Equity
1.60%
Trailing 12-Months
Asset Growth
50.12%
Trailing 12-Months
Company Description
Extendicare
Extendicare Inc. operates across Canada, delivering a wide array of vital care and support services specifically designed for the senior population through its various subsidiaries. The company's diverse service portfolio includes long-term care facilities, a range of retirement living options, and comprehensive home-based health services. These home health offerings span professional nursing care, various rehabilitative therapies (including occupational, physical, and speech therapy), and assistance with everyday activities. Additionally, Extendicare offers contract and consulting expertise to external entities. The organization oversees an extensive network consisting of 119 long-term care residences and retirement communities, alongside its dedicated home health care operations. These services are provided under prominent brand names such as Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network. Founded in 1968, Extendicare Inc. is headquartered in Markham, Canada.
EXE Stock 12 Month Forecast
Average Price Target
C$38.75
▲(2.22% Upside)